Literature DB >> 16520363

Analgesia for total hip and knee arthroplasty: a multimodal pathway featuring peripheral nerve block.

Terese T Horlocker1, Sandra L Kopp, Mark W Pagnano, James R Hebl.   

Abstract

Patients undergoing total hip and knee arthroplasty experience substantial and sustained postoperative pain. Inadequate analgesia may impede physical therapy and rehabilitative efforts and delay hospital dismissal. Traditionally, postoperative analgesia after total joint replacement was provided by either intravenous patient-controlled analgesia or epidural analgesia. Each, however, had disadvantages as well as advantages. Peripheral nerve blockade of the lumbosacral plexus has emerged as an alternative analgesic approach. In several studies, unilateral peripheral block provided a quality of analgesia and functional outcomes similar to those of continuous epidural analgesia and superior to those of systemic analgesia, but with fewer side effects because of their opioid-sparing properties. Peripheral nerve block techniques may be the optimal analgesic method following total joint arthroplasty.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16520363     DOI: 10.5435/00124635-200603000-00003

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  28 in total

1.  Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.

Authors:  Stefania Vaglio; Domenico Prisco; Gianni Biancofiore; Daniela Rafanelli; Paola Antonioli; Michele Lisanti; Lorenzo Andreani; Leonardo Basso; Claudio Velati; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2015-12-15       Impact factor: 3.443

Review 2.  [The value of regional and general anaesthesia in orthopaedic surgery].

Authors:  O Vicent; M Hübler; S Kirschner; T Koch
Journal:  Orthopade       Date:  2007-06       Impact factor: 1.087

Review 3.  Factors influencing early rehabilitation after THA: a systematic review.

Authors:  Vivek Sharma; Patrick M Morgan; Edward Y Cheng
Journal:  Clin Orthop Relat Res       Date:  2009-03-10       Impact factor: 4.176

Review 4.  Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit.

Authors:  Adeleke D Adewumi; Christine E Staatz; Samantha A Hollingworth; Jason P Connor; Rosa Alati
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

Review 5.  [Concepts for perioperative pain therapy. A critical stocktaking].

Authors:  S Reichl; E Pogatzki-Zahn
Journal:  Anaesthesist       Date:  2009-09       Impact factor: 1.041

6.  Implementation of an accelerated mobilization protocol following primary total hip arthroplasty: impact on length of stay and disposition.

Authors:  Samuel S Wellman; Andrew C Murphy; Diane Gulcynski; Stephen B Murphy
Journal:  Curr Rev Musculoskelet Med       Date:  2011-09

Review 7.  Preventive analgesia and novel strategies for the prevention of chronic post-surgical pain.

Authors:  Hance Clarke; Michael Poon; Aliza Weinrib; Rita Katznelson; Kirsten Wentlandt; Joel Katz
Journal:  Drugs       Date:  2015-03       Impact factor: 9.546

8.  Management plan to reduce risks in perioperative care of patients with presumed obstructive sleep apnea syndrome.

Authors:  Bhargavi Gali; Francis X Whalen; Peter C Gay; Eric J Olson; Darrell R Schroeder; David J Plevak; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2007-10-15       Impact factor: 4.062

Review 9.  Anaesthesiological problems in patients with rheumatoid arthritis undergoing orthopaedic surgeries.

Authors:  Barbara Lisowska; Lidia Rutkowska-Sak; Pawel Maldyk; Renata Cwiek
Journal:  Clin Rheumatol       Date:  2008-01-18       Impact factor: 2.980

10.  Multimodal pain management after total hip and knee arthroplasty at the Ranawat Orthopaedic Center.

Authors:  Aditya V Maheshwari; Yossef C Blum; Laghvendu Shekhar; Amar S Ranawat; Chitranjan S Ranawat
Journal:  Clin Orthop Relat Res       Date:  2009-02-13       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.